Skip to main content
. 2022 Nov 4;23(4):231–240. doi: 10.1007/s10048-022-00700-w

Table 3.

Five studies included in the analysis

Study Methods # cases reported Gene Variant/type/allele Position Gen/protein inheritance Sanger confirmation Functional studies
Beck et al. [10] Whole exome sequencing (WES) 5 cases (4 affected/one healthy) CTBP1

c.991CT, p.Arg342Trp

Missense

Heterozygous

Exon 8/PLDLS binding cleft domain

De novo = 3

Somatic mosaicism = 2

Yes No (functional studies of these same cases were reported in study #3)
Sommerville et al. [11] WES mitochondrial genome sequencing 1 CTBP1

c.991CT, p.Arg342Trp

Missense

Heterozygous

Exon 8/PLDLS binding cleft domain De novo Yes Decreased respiratory chain activities of complexes I and IV
Beck et al. [12] WES 7 CTBP1

c.991CT, p.Arg342Trp

Missense

Heterozygous

Exon 8/PLDLS binding cleft domain De novo Not mentioned in this report

-Proteomic analysis: reduced interaction of chromatin-modifying factors with the CtBP1 mutant

-Genome-wide transcriptome analysis in human glioblastoma cell lines expressing the CtBP1 mutation: Showed changes in the expression profiles of genes that control multiple cellular processes

-Patient-derived dermal fibroblasts were more sensitive to apoptosis during glucose deprivation

Bhatia et al. [13] WES 1 CTBP1

c.991CT, p.Arg342Trp

Missense

Heterozygous

Exon 8/PLDLS binding cleft De novo Yes No
Khamirani et al. [14] WES 1 CTBP1

c.1315_1316delCA, p.Gln439ValfsTer84

2-pb deletion

Heterozygous

Not analyzed Consanguineous parents. A proband with an affected brother with a similar clinical condition (not studied) Yes No